Approach to Early Rectal Cancer in 2026: The Emerging Role of Endoscopic Intermuscular Dissection

Background/Objectives: The management of early rectal cancer is increasingly shifting toward organ-preserving strategies aimed at maintaining oncological efficacy while minimizing the morbidity and functional impairment associated with radical surgery. However, endoscopic submucosal dissection (ESD) may provide inadequate deep vertical margins in lesions with deep submucosal invasion. Endoscopic intermuscular dissection (EID) has recently emerged as a deeper resection technique that may address this therapeutic gap. This review summarizes current approaches to early rectal cancer and critically evaluates the emerging role of EID. Methods: A narrative review was conducted using PubMed and Scopus, including relevant English-language studies available through August 2026. Evidence on early rectal cancer, histopathological risk stratification, pre-resection assessment, surgical and endoscopic local excision techniques, oncological and functional outcomes, and management after non-curative resection was reviewed, with particular emphasis on EID. Recent studies and relevant guidelines were considered alongside earlier landmark publications. As a narrative review, the evidence was selected and synthesized without a systematic review protocol. Results: EID enables dissection between the circular and longitudinal layers of the muscularis propria, providing deeper vertical clearance than ESD while preserving rectal wall integrity. Available studies report en bloc and R0 resection rates of approximately 94–96% and 81–83%, respectively, with encouraging three-year oncological outcomes in selected patients with low- and intermediate-risk deep submucosal invasive cancer. However, current evidence is derived mainly from expert centers and limited cohorts, and uncertainties remain regarding proximal rectal lesions, subsequent completion surgery, and long-term oncological outcomes. Conclusions: EID represents a promising organ-preserving option for selected early rectal cancers with deep submucosal invasion, but should not yet be considered standard practice. In selected cT1N0 rectal lesions with suspected deep submucosal invasion, EID may provide greater vertical clearance when conventional ESD is unlikely to achieve an adequate deep resection margin. Expert optical assessment with virtual chromoendoscopy, pelvic MRI and, when appropriate, endorectal ultrasound (EUS), inform pre-resection staging and patient selection. Careful patient selection and multidisciplinary management remain essential, while prospective multicenter studies with longer follow-up are required to establish its oncological safety, reproducibility, and role in clinical practice.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-17
DOI
https://doi.org/10.3390/diagnostics16223826
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Approach to Early Rectal Cancer in 2026: The Emerging Role of Endoscopic Intermuscular Dissection

David James Tate, Gianluca Andrisani, Alessandro Repici, Giulio Antonelli et al.
3 links
Diagnostics
Colorectal Cancer Surgical Treatments
article

Approach to Early Rectal Cancer in 2026: The Emerging Role of Endoscopic Intermuscular Dissection

David James Tate, Gianluca Andrisani, Alessandro Repici, Giulio Antonelli, Simone Schiavone, Maria Eva Argenziano, Federico Iacopini, Roberta Maselli, Cesare Hassan
article en

Abstract

Background/Objectives: The management of early rectal cancer is increasingly shifting toward organ-preserving strategies aimed at maintaining oncological efficacy while minimizing the morbidity and functional impairment associated with radical surgery. However, endoscopic submucosal dissection (ESD) may provide inadequate deep vertical margins in lesions with deep submucosal invasion. Endoscopic intermuscular dissection (EID) has recently emerged as a deeper resection technique that may address this therapeutic gap. This review summarizes current approaches to early rectal cancer and critically evaluates the emerging role of EID. Methods: A narrative review was conducted using PubMed and Scopus, including relevant English-language studies available through August 2026. Evidence on early rectal cancer, histopathological risk stratification, pre-resection assessment, surgical and endoscopic local excision techniques, oncological and functional outcomes, and management after non-curative resection was reviewed, with particular emphasis on EID. Recent studies and relevant guidelines were considered alongside earlier landmark publications. As a narrative review, the evidence was selected and synthesized without a systematic review protocol. Results: EID enables dissection between the circular and longitudinal layers of the muscularis propria, providing deeper vertical clearance than ESD while preserving rectal wall integrity. Available studies report en bloc and R0 resection rates of approximately 94–96% and 81–83%, respectively, with encouraging three-year oncological outcomes in selected patients with low- and intermediate-risk deep submucosal invasive cancer. However, current evidence is derived mainly from expert centers and limited cohorts, and uncertainties remain regarding proximal rectal lesions, subsequent completion surgery, and long-term oncological outcomes. Conclusions: EID represents a promising organ-preserving option for selected early rectal cancers with deep submucosal invasion, but should not yet be considered standard practice. In selected cT1N0 rectal lesions with suspected deep submucosal invasion, EID may provide greater vertical clearance when conventional ESD is unlikely to achieve an adequate deep resection margin. Expert optical assessment with virtual chromoendoscopy, pelvic MRI and, when appropriate, endorectal ultrasound (EUS), inform pre-resection staging and patient selection. Careful patient selection and multidisciplinary management remain essential, while prospective multicenter studies with longer follow-up are required to establish its oncological safety, reproducibility, and role in clinical practice.

DiagnosticsVol. 16(22)
Humanitas University (IT), Ghent University Hospital (BE), Ghent University (BE), Campus Bio Medico University Hospital (IT), IRCCS Humanitas Research Hospital (IT)
Good health and well-being
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon